Biolase
| Public | |
| Traded as | NASDAQ: BIOL |
| Industry | Medical Equipment |
| Founded | 1984 |
| Headquarters | Irvine, California, United States |
| Revenue | $48.5 Million[1] (2015) |
| $-20.3 Million[1] (2015) | |
| Website | http://www.biolase.com |
Biolase, Inc. (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including CAD/CAM scanners. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.
References
- 1 2 "BIOLASE Reports 2015 Fourth Quarter and Year-End Results". businesswire.com. Retrieved 2016-04-08.
External links
This article is issued from Wikipedia - version of the Tuesday, April 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.